Varma Raja, Aronow Wilbert S, McClung John A, Garrick Renee, Vistainer Paul F, Weiss Melvin B, Belkin Robert N
Department of Medicine, Cardiology and Renal Divisions, Westchester Medical Center/New York Medical College, Valhalla, New York 10595, USA.
Am J Cardiol. 2005 Mar 15;95(6):742-3. doi: 10.1016/j.amjcard.2004.11.025.
Of 137 patients (mean age 63 years) who underwent hemodialysis for chronic renal failure, 65 (47%) had mitral valve calcium, mitral annular calcium, or aortic valve calcium. Thirty-eight of 65 patients (59%) who had valve calcium died at 3.5-year follow-up versus 21 of 72 patients (29%) who did not have valve calcium and who died at 4.3-year follow-up (p = 0.0005).
在137例因慢性肾衰竭接受血液透析的患者(平均年龄63岁)中,65例(47%)有二尖瓣钙化、二尖瓣环钙化或主动脉瓣钙化。65例有瓣膜钙化的患者中,38例(59%)在3.5年的随访期内死亡,而72例无瓣膜钙化的患者中,21例(29%)在4.3年的随访期内死亡(p = 0.0005)。